Subjective and neurocognitive profiling of clinical doses of 3,4-methylenedioxymethamphetamine (MDMA) in healthy volunteers: implications for therapeutic use. - Ramaekers JG; Kuypers KPC; Vollenweider FX (Molecular psychiatry, 2026)